Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease

NACompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

April 1, 2019

Study Completion Date

April 1, 2019

Conditions
Cardiovascular DiseaseHigh Blood Pressure
Interventions
BEHAVIORAL

Million Hearts ABCS 6 Months

The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S).

BEHAVIORAL

Million Hearts ABCS 9 Months

The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S).

BEHAVIORAL

Million Hearts ABCS 12 Months

The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S).

BEHAVIORAL

Million Hearts ABCS 15 Months

The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S).

BEHAVIORAL

Standard Care Regimen 9 Months

BEHAVIORAL

Standard Care Regimen 12 Months

BEHAVIORAL

Standard Care Regimen 15 Months

BEHAVIORAL

Standard Care Regimen 18 Months

BEHAVIORAL

Standard Care Regimen 21 Months

BEHAVIORAL

Standard Care Regimen 24 Months

BEHAVIORAL

Standard Care Regimen 27 Months

BEHAVIORAL

Follow Up Post Intervention 21 Months

BEHAVIORAL

Follow Up Post Intervention 24 Months

BEHAVIORAL

Follow Up Post Intervention 27 Months

BEHAVIORAL

Follow Up Post Intervention 30 Months

BEHAVIORAL

Follow Up Post Intervention 33 Months

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

lead

NYU Langone Health

OTHER

NCT02646488 - Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease | Biotech Hunter | Biotech Hunter